IL1B and serum lipopolysaccharide activity: Our previous results showed that simvastatin dose-dependently decreased overproduction of TNF-α and IL-1β in endotoxemia [19], therefore it is conceivable that in this study, simvastatin targets both inflammatory pathways to protect renal tubules against LPS.